Summary

Galderma S.A. is a Swiss pharmaceutical company headquartered in Zug, Switzerland, specializing exclusively in dermatology. Founded in 1981 as a joint venture between L'Oréal and Nestlé, the company has evolved into the world's largest independent dermatology company. Galderma focuses on three core business segments: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. The company offers a comprehensive portfolio of premium brands including Cetaphil, Restylane, Azzalure, Dysport, and Sculptra, serving patients and consumers in over 100 countries. With approximately 6,500 employees globally, Galderma maintains a strong research and development presence across six sites worldwide. The company went public in 2024 with an IPO on the SIX Swiss Exchange, marking a significant milestone in its growth trajectory. Galderma's mission is to advance dermatology for every skin story, combining scientific innovation with trusted partnerships with healthcare professionals to deliver superior outcomes for diverse skin needs.

Job description

Megabrand Strategy & Growth Leadership

Lead development of U.S. megabrand strategies for Cetaphil and Differin, translating consumer and market understanding into actionable growth plans.
Partner with Brand, Commercial, Media, HCP, and Global teams to shape long-range strategic direction and annual business planning.
Identify portfolio, category, and whitespace opportunities that accelerate penetration, household growth, and market share.
Serve as a strategic thought partner to Marketing Leadership and the U.S. Leadership Team on key business decisions, growth opportunities, and enterprise initiatives.
Support strategic assessments of new business opportunities, partnerships, acquisitions, and emerging market trends.

Consumer & Market Intelligence

Lead the U.S. Consumer and Market Insights function, establishing a best-in-class learning agenda that informs brand, innovation, and commercial decisions.
Translate consumer, shopper, retailer, dermatologist, and category insights into clear recommendations that influence action.
Oversee foundational learning programs including Brand Health Tracking, segmentation, category architecture, innovation testing, communication development, and claims validation.
Monitor competitive activity, category trends, and emerging consumer behaviors to identify risks and opportunities.

Insights-to-Action Leadership

Ensure insights are translated into strategic recommendations rather than remaining isolated as research outputs.
Partner with Brand teams to shape communication strategies, innovation pipelines, positioning frameworks, and go-to-market plans.
Drive adoption of insights across the organization through compelling storytelling, executive presentations, and clear business recommendations.
Build frameworks that connect consumer understanding to business performance and investment decisions.

Measurement & Marketing Effectiveness

Lead marketing measurement capabilities including Commercial Mix Modeling, Brand Health, incrementality, media effectiveness, and business performance tracking.
Establish integrated measurement frameworks that provide a holistic view of brand and business health.
Translate complex data into actionable recommendations that optimize marketing investments and accelerate growth.

Cross-Functional Leadership & Influence

Serve as a highly collaborative partner across Brand, Commercial, Media, Sales, HCP, Innovation, Finance, and Global teams.
Align stakeholders around strategic priorities and create clarity in complex business situations.
Foster an insight-led culture by embedding consumer-centric thinking into business planning and decision-making.
Mentor and develop team members while building organizational capability in strategic thinking and consumer understanding.

Success Measures

Increased brand penetration, equity, and market share across Cetaphil and Differin.
Strong adoption of insights and strategy recommendations across the organization.
Improved effectiveness of marketing investments and business decision-making.
Identification of new growth opportunities, innovation platforms, and strategic priorities.
High levels of cross-functional engagement, trust, and influence.
Development of a best-in-class insights and strategy capability for the U.S. business.

Requirements

Bachelor’s degree required; MBA preferred.
10+ years of experience in consumer marketing, brand strategy, category management, consumer insights, consulting, or related strategic leadership roles.
Demonstrated success influencing business strategy through consumer, shopper, and marketplace understanding.
Experience leading complex cross-functional initiatives in a matrixed organization.
Strong strategic planning and growth strategy capabilities.
Experience with consumer research methodologies, segmentation, brand health, innovation development, and marketing effectiveness measurement.
Exceptional communication and storytelling skills with the ability to influence senior leaders.
Proven ability to translate complexity into actionable business recommendations.
Strong financial and commercial acumen.
Beauty, skincare, health, wellness, OTC, or adjacent consumer packaged goods experience preferred.

Benefits

Health insurance
401(k) plan with employer match
Paid time off
Hybrid work schedules

Company overview

Galderma S.A. is a Swiss pharmaceutical company headquartered in Zug, Switzerland, specializing exclusively in dermatology. Founded in 1981 as a joint venture between L'Oréal and Nestlé, the company has evolved into the world's largest independent dermatology company. Galderma focuses on three core business segments: Injectable Aesthetics, Dermatological Skincare, and Therapeutic Dermatology. The company offers a comprehensive portfolio of premium brands including Cetaphil, Restylane, Azzalure, Dysport, and Sculptra, serving patients and consumers in over 100 countries. With approximately 6,500 employees globally, Galderma maintains a strong research and development presence across six sites worldwide. The company went public in 2024 with an IPO on the SIX Swiss Exchange, marking a significant milestone in its growth trajectory. Galderma's mission is to advance dermatology for every skin story, combining scientific innovation with trusted partnerships with healthcare professionals to deliver superior outcomes for diverse skin needs.